Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Madalina E. Carter-Timofte; Rozanne Arulanandam; Naziia Kurmasheva; Kathy Fu; Geneviève Laroche; Zaid Taha; Zaid Taha; Demi van der Horst; Lena Cassin; Renée M. van der Sluis; Enrico Palermo; Daniele Di Carlo; David Jacobs; Glib Maznyi; Taha Azad; Taha Azad; Ragunath Singaravelu; Fanghui Ren; Anne Louise Hansen; Manja Idorn; Christian K. Holm; Martin R. Jakobsen; Julien van Grevenynghe; John His

Journal title: Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.

Journal number: 23738227

Journal publisher: ACS Publications

Published year: 2021

DOI identifier: 10.1021/acsinfecdis.1c00278

ISSN: 2373-8227